Newsroom

Portrait of Christian Scherf (left) und Josef Penninger (right)
Interview
The message is clear: The Helmholtz Centre for Infection Research (HZI) aims to become one of the world's premier infection research institutes. Professor Josef Penninger, Scientific Director of the HZI since 1 July 2023, has set the bar high. Christian Scherf, the Administrative Director of the HZI since 1 January 2023, is going to do everything in his power to support him.
05.12.2023
Dirk Heinz and Josef Penninger
News
In July of this year, the new Scientific Director, Prof Josef Penninger, took office at the Helmholtz Centre for Infection Research (HZI). He succeeds Prof Dirk Heinz, who stepped down from his position after 13 years and began establishing the new "Molecular Structural Biology" research department at the HZI. On 4 December 2023, Dirk Heinz was thanked for his many years of successful work and the handover of office to Josef Penninger was celebrated in the presence of renowned guests from science and politics.
05.12.2023
Hortense Slevogt
Portrait
Professor Hortense Slevogt is an expert in the field of respiratory and lung infections and immunology. Both as a renowned researcher and a doctor. If you ask her for a catchy name for what she does, she doesn't hesitate: "I build bridges." Bridges between research and clinical practice. Slevogt has been a W3 professor at Hannover Medical School since 2022 and is a senior physician for clinical infectiology with the Department of Pneumology and Infectiology. She is also the head of the "Dynamics of respiratory infections" research group at the HZI in Braunschweig. In her role as a clinical scientist, she finds it extremely fulfilling to translate discoveries from the laboratory and clinical studies into direct benefits for patients.
04.12.2023
Press image
News
To ensure that vaccines provide strong and lasting immunization, it is often necessary to supplement the actual vaccine (antigen) with additives that stimulate the immune system: adjuvants. Today, only a few substances have been approved for use as adjuvants. In the journal Angewandte Chemie, a research team has now introduced a spectrum of potential adjuvants. They started with the immune stimulant α-glactosyl ceramide (α-GalCer) and synthesized many different variants from a set of four building blocks.
04.12.2023
Tabletten
News
The Federal Ministry of Education and Research (BMBF) is funding the establishment of a German-Ukrainian core of excellence to help discover new anti-infectives and make them available for medical purposes. The core of excellence, funded with 2.5 million euros, is to be located in the western Ukrainian city of Lviv - in collaboration with Saarland University and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). In the long term, the core of excellence should establish itself as an independent research institution and strengthen scientific relations between Germany and Ukraine. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in cooperation with Saarland University.
28.11.2023
AI Image symbolique, personne en blouse blanche avec stéthoscope en arrière-plan
News
Improving health care and strengthening personalized medicine: A new research center for Artificial Intelligence (AI) and causal methods in medicine (CAIMed - Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine) is being established in Lower Saxony. Researchers in computer science and medicine from Hannover, Göttingen and Braunschweig will develop innovative methods and applications of artificial intelligence. The Ministry of Science and Culture and the Volkswagen Foundation are providing 15 million euros from the joint "zukunft.niedersachsen" program for the next five years. Prof Wolfgang Nejdl from the L3S Research Centre at the Leibniz University of Hanover (LUH) will act as spokesperson. Two of the new research groups will be set up at sites of the Helmholtz Centre for Infection Research (HZI).
22.11.2023

HZI in the media

Vor allem durch die Coronapandemie sind Forschende des Helmholtz-Zentrums für Infektionsforschung in den vergangenen Jahren bundesweit bekannt geworden. Auf welche Themen die Einrichtung für die Zukunft setzt.

20.03.2026
|
Deutsches Ärzteblatt

... beschäftigt sich daneben unter dem Dach des Helmholtz Institutes für Pharmazeu­tische Forschung Saarland (HIPS) ...

18.03.2026
|
Biermann Medizin

... Ausbau von Produktions- und Vermarktungskapazitäten.

 

Das Helmholtz-Zentrum für Infektionsforschung HZI begrüßt den Erhalt der GMP- ...

18.03.2026
|
Bionity.COM

... der Universität zu Lübeck, des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig, der Medizinischen Hochschule Hannover ...

17.03.2026
|
Biermann Medizin

Vorsorge Das Coronavirus hält die Welt nicht mehr in Atem. Doch was, wenn ein ­anderer gefährlicher Erreger auftaucht? So wappnet sich unser Gesundheitssystem

16.03.2026
|
Apotheken Umschau

... stumpfen ab“, erklärt Marc Brönstrup vom Helmholtz-Zentrum für Infektionsforschung in Braunschweig. Neue Antibiotika sind dringend ...

14.03.2026
|
ARD Mediathek

... der Medizinischen Hochschule Hannover und dem Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig neue Wirkstoffe ...

13.03.2026
|
MTA Dialog

... späten 1990ern hob sie der am Saarbrücker Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) tätige ...

08.03.2026
|
Saarbrücker Zeitung

European institutions, including Germany’s Helmholtz Institute for RNA-based Infection Research, Helmholtz Center for Infection Research,

06.03.2026
|
Clinical Lab Products

Die Zellen kontrollieren die Reaktion des Immunsystems und verhindern Schäden durch Selbstangriffe. Forschende arbeiten daran, sie zur Therapie einzusetzen.

05.03.2026
|
NDR Norddeutscher Rundfunk

Nachwuchsgruppe „Nanoinfektionsbiologie“ am HZI. Diese Lücke soll das Projekt ONEMUC (Respiratorischer Mukus als One Health-Schnittstelle) ...

03.03.2026
|
DeutschesGesundheitsPortal

Hochschule Hannover (MHH) und des Helmholz-Zentrums für Infektionsforschung (HZI) erforschen im Rahmen des Projektes StopPSC ( ...

03.03.2026
|
Biermann Medizin

Register now for the HZI-Newsletter